Arkolith/Insider Trading/HOTH/Form 4

Knie Robb

CEO and President, DirectorHoth Therapeutics, Inc. (HOTH) · full profile →Form 4 · filed Sep 20, 2022
Net Buying
Open-Market Buys
$4K
Open-Market Sells
$0
Net Open-Market Flow
$4K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 19, 2022Buy(P)10K$0.39$4K828K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-22-057162) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML